Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis

NCT04664803 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2020-12-11

No results posted yet for this study

Summary

This is a multi-center, double-blind, randomized, active controlled, parallel group phase 4 clinical trial to re-confirm the efficacy and safety of cefetamet pivoxil formulation in sinusitis patients

Conditions

  • Acute Sinusitis

Interventions

DRUG

Cefecin Tab.

DRUG

Omnicef Cap.

Sponsors & Collaborators

  • Korea United Pharm. Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-06-28
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04664803 on ClinicalTrials.gov